MAVACOXIB, 95%, 50mg

Pyridine-2,4-diamine, 95.0%, 250mg

(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-5-yl)propanamido]hexanoic acid; acetic acid, 98%, 5g

tert-Butyl 6-hydroxy-2-azaspiro[3.4]octane-2-carboxylate, 95.0%, 250mg

(E)-4,4,5,5-Tetramethyl-2-(pent-1-en-1-yl)-1,3,2-dioxaborolane, 98.0%, 5g

5-(4'-(BROMOMETHYL)-[1,1'-BIPHENYL]-2-YL)-2-TRITYL-2H-TETRAZOLE, 95%, 1g

2-({[(4-methylphenyl)amino]carbonyl}amino)-1,3-thiazole-4-carboxylic acid, 95.0%, 500mg

Pyrrole-2-carbonitrile, 97.00%, 100g

1-Amino-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 98%, 1g

6-chloro-1H,2H,3H-imidazo[4,5-b]pyridine-2-thione, 97%, 250mg

Methyl 3-Methyl-4-nitrobenzoate, 97.0%, 10g

Methyl 6-bromo-1H-indole-2-carboxylate, 95.0%, 5g

4-Cyano-4''-propyl-p-terphenyl>98.0%(GC)1g